Lexicon Pharmaceuticals (LXRX) Change in Accured Expenses: 2009-2024
Historic Change in Accured Expenses for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $14.8 million.
- Lexicon Pharmaceuticals' Change in Accured Expenses rose 86.36% to -$892,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $995,000, marking a year-over-year increase of 109.60%. This contributed to the annual value of $14.8 million for FY2024, which is 129.33% up from last year.
- Lexicon Pharmaceuticals' Change in Accured Expenses amounted to $14.8 million in FY2024, which was up 129.33% from $6.5 million recorded in FY2023.
- Lexicon Pharmaceuticals' 5-year Change in Accured Expenses high stood at $14.8 million for FY2024, and its period low was -$21.0 million during FY2020.
- Over the past 3 years, Lexicon Pharmaceuticals' median Change in Accured Expenses value was $6.5 million (recorded in 2023), while the average stood at $7.1 million.
- Its Change in Accured Expenses has fluctuated over the past 5 years, first slumped by 204.34% in 2020, then skyrocketed by 8,392.11% in 2023.
- Over the past 5 years, Lexicon Pharmaceuticals' Change in Accured Expenses (Yearly) stood at -$21.0 million in 2020, then spiked by 32.48% to -$14.2 million in 2021, then spiked by 100.54% to $76,000 in 2022, then spiked by 8,392.11% to $6.5 million in 2023, then skyrocketed by 129.33% to $14.8 million in 2024.